<DOC>
	<DOCNO>NCT01326325</DOCNO>
	<brief_summary>Long-term opioid therapy commonly administer management severe cancer pain . Increasing dos opioids titrate effect analgesia achieve intolerable adverse effect occur . Ketamine , N-methyl-D-aspartate ( NMDA ) receptor antagonist , report improve analgesia patient uncontrolled pain receive high dos opioids . This study aim determine effectiveness ketamine adjuvant opioids relieve cancer pain .</brief_summary>
	<brief_title>Efficacy Low Analgesic Doses Ketamine Associated With Opioids Refractory Cancer Pain Treatment</brief_title>
	<detailed_description>Main objective : To show low analgesic dos ketamine intravenous infusion 4 day associate opioids well relieve refractory cancer pain opioids without ketamine . This study prospective study , multicenter ( 11 centre ) , consist 3 phase : - randomized control double blind phase 5 day 2 parallel group 38 patient : ketamine ( association high opioids ) , intravenous injection 4 day , versus placebo ( association high opioids ) , intravenous injection 4 day ; - open-label phase maximum 4 day , ketamine PanpharmaÂ® administer intravenous infusion hospitalize patient still uncontrolled pain persisting recurrent ; - observational phase : start discharge patient , maximal period 6 months.The inclusion period 18 month , total duration study 2 year . 76 patient expect : 38 treat opioids ketamine ; 38 treat opioids placebo . Success define decrease daily pain score 50 % 4 day . The expected rate success placebo group 10 % whereas expect rate success ketamine group 30 % . Primary outcome ( pain score 11-point numerical scale ) evaluate everyday well secondary outcome ( patient clinician global impression change , opioid consumption , adverse reaction , patient satisfaction pain relief , sleep interference score ) . Vital parameter ( cardiac frequency , respiratory frequency arterial blood pressure ) check everyday , many time day : every hour four hour begin treatment , every four hour ; every hour two hour follow dose shift ) .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Hospitalized cancer patient ( inform conscious cancer diagnostic ) Undergoing opioid treatment 15 day least Refractory pain ( score high 5 10point numerical pain rating scale ) Ability score pain numerical pain rating scale Patient write agreement Ketamine contraindication Methadone NMDAantagonist treatment Karnofsky index 10 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Refractory pain</keyword>
	<keyword>Uncontrolled pain</keyword>
	<keyword>Ketamine</keyword>
</DOC>